$14.99
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Enanta Pharma: Insider buying and selling updated today.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Enanta Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 6.57K shares worth $142.43K, meanwhile, insiders have report no purchases in the last 30 days.
Jul 15, 2024 | Scott Rottinghaus | CHIEF MEDICAL OFFICER | -6.57K | $12.48 | -$142.43K | SELL | -23.23% | 21.72K | Jul 11 - Jul 15 | View |
Jun 17, 2024 | Lynn Tara Kieffer | CHIEF PRODUCT STRATEGY OFFICER | -7.27K | $12.33 | -$89.59K | SELL | -18.35% | 32.34K | Jun 17 | View |
Dec 15, 2023 | Terry Vance | DIRECTOR | -15.29K | $9.12 | -$139.49K | SELL | -72.51% | 5.80K | Dec 13 | View |
Dec 06, 2023 | Brendan Luu | SR. VP, BUSINESS DEV. | -2.13K | $9.63 | -$20.46K | SELL | -5.47% | 36.74K | Dec 05 | View |
Dec 06, 2023 | Lynn Tara Kieffer | SR. VP, NEW PROD. STRAT. & DEV | -2.13K | $9.63 | -$20.46K | SELL | -5.40% | 37.26K | Dec 05 | View |
Dec 06, 2023 | Nathaniel S Gardiner | SR. VP & GENERAL COUNSEL | -2.41K | $9.63 | -$23.23K | SELL | -2.26% | 104.08K | Dec 05 | View |
Dec 06, 2023 | Scott Rottinghaus | SR. VP & CMO | -534.00 | $9.63 | -$5.14K | SELL | -1.98% | 26.47K | Dec 05 | View |
Dec 06, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP, R&D & CSO | -2.41K | $9.63 | -$23.23K | SELL | -0.65% | 370.69K | Dec 05 | View |
Dec 06, 2023 | PAUL MELLETT | SR. VP, FINANCE & ADMIN. & CFO | -2.41K | $9.63 | -$23.23K | SELL | -2.51% | 93.55K | Dec 05 | View |
Dec 06, 2023 | Jay Luly | PRESIDENT AND CEO | -7.23K | $9.63 | -$69.62K | SELL | -0.89% | 806.79K | Dec 05 | View |
Mar 17, 2023 | PAUL MELLETT | TREASURER AND CFO | 0.00 | $29.21 | -$317.64K | SELL-OPTIONS | 0.00% | 97.56K | Mar 15 | View |
Mar 17, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP & CSO | 0.00 | $29.22 | -$424.01K | SELL-OPTIONS | 0.00% | 374.70K | Mar 15 | View |
Mar 14, 2023 | Jay Luly | PRESIDENT AND CEO | 0.00 | $29.58 | -$869.86K | SELL-OPTIONS | 0.00% | 819.81K | Mar 13 | View |
Feb 13, 2023 | PAUL MELLETT | TREASURER AND CFO | -5.00K | $53.76 | -$268.82K | SELL | -5.65% | 83.46K | Feb 09 | View |
Dec 16, 2022 | Jay Luly | PRESIDENT AND CEO | 0.00 | $29.41 | -$918.81K | SELL-OPTIONS | 0.00% | 773.80K | Dec 16 | View |
Apr 05, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.12 | -$2.58M | SELL-OPTIONS | 0.00% | 34.98K | Apr 01 - Apr 04 | View |
Mar 22, 2022 | BRUCE CARTER | DIRECTOR | 0.00 | $46.70 | -$253.49K | SELL-OPTIONS | 0.00% | 0.00 | Mar 21 | View |
Mar 03, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.83 | -$984.48K | SELL-OPTIONS | 0.00% | 34.98K | Mar 01 - Mar 02 | View |
Jan 13, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $55.00 | -$379.24K | SELL-OPTIONS | 0.00% | 32.90K | Jan 11 | View |
Dec 03, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | -842.00 | $65.84 | -$629.66K | SELL | -2.50% | 32.90K | Dec 01 | View |
Nov 02, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $66.70 | -$347.20K | SELL-OPTIONS | 0.00% | 26.94K | Nov 01 | View |
Oct 13, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.80 | -$467.07K | SELL-OPTIONS | 0.00% | 26.94K | Oct 08 - Oct 11 | View |
Sep 17, 2021 | Jay Luly | PRESIDENT AND CEO | -4.52K | $59.06 | -$266.70K | SELL | -0.66% | 676.97K | Sep 15 | View |
Jan 08, 2021 | PAUL MELLETT | TREASURER AND CFO | -6.00K | $45.58 | -$273.46K | SELL | -8.85% | 61.76K | Jan 08 | View |
Jan 06, 2020 | Paul J Mellett | — | -8.54K | $61.19 | -$683.22K | TAX | -17.57% | 40.05K | Dec 16 - Jan 02 | View |
Browse insider trades on all stocks.